Nyxoah (NYXH) Cash from Financing Activities (2025 - 2026)
Nyxoah's quarterly Cash from Financing Activities came in at $468298.3 in Q1 2026, up 160.99% year-on-year from $179434.1 in Q1 2025, and up 160.99% quarter-over-quarter from -$767875.6 in Q1 2025.
Nyxoah has reported Cash from Financing Activities for 2 years, with the latest figure at $468298.3 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | -255.24 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -308.70 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | -50.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | -147.90 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | -48.13 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -11.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -230.34 Mn |
| 10 | Nyxoah | 1,248.49 | 1,248.49 | 4.26 Mn | 468,298.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 468,298.26 |
| Mar 31, 2026 | 468,298.26 |
| Mar 31, 2025 | -767,875.64 |
| Mar 31, 2025 | -767,875.64 |